Abbott Laboratories
F:ABL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Abbott Laboratories
F:ABL
|
US |
|
A
|
Anglo American Platinum Ltd
SWB:RPHA
|
ZA |
|
E
|
Eni SpA
XMUN:ENI
|
IT |
|
H
|
Home Depot Inc
SGO:HD
|
US |
|
E
|
Erlebnis Akademie AG
F:EAD
|
DE |
|
M
|
MGIC Investment Corp
XMUN:MGC
|
US |
|
N
|
National Bank of Canada
F:NBC
|
CA |
|
Amadeus IT Group SA
MAD:AMS
|
ES |
|
I
|
Imperial Brands PLC
XMUN:ITB
|
UK |
|
H
|
Henry Schein Inc
XMUN:HS2
|
US |
|
N
|
Nordstrom Inc
XMUN:NRD
|
US |
|
R
|
Radian Group Inc
F:RAG
|
US |
|
S
|
Somboon Advance Technology PCL
SET:SAT
|
TH |
|
3
|
3M Co
XMUN:MMM
|
US |
|
V
|
Vector Group Ltd
F:VGR
|
US |
|
H
|
Helmerich and Payne Inc
XMUN:HPC
|
US |
|
C
|
China Overseas Land & Investment Ltd
XBER:CPP
|
HK |
|
Koninklijke Ahold Delhaize NV
F:AHOG
|
NL |
|
H
|
Helmerich and Payne Inc
F:HPC
|
US |
|
F
|
Funko Inc
F:FU2
|
US |
|
Lithia Motors Inc
F:LMO
|
US |
Wall St Price Targets
ABL Price Targets Summary
Abbott Laboratories
According to Wall Street analysts, the average 1-year price target for ABL is 105.43 EUR with a low forecast of 89.6 EUR and a high forecast of 122.99 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ABL's stock price target?
Price Target
105.43
EUR
According to Wall Street analysts, the average 1-year price target for ABL is 105.43 EUR with a low forecast of 89.6 EUR and a high forecast of 122.99 EUR.
What is the Revenue forecast for Abbott Laboratories?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 7 years is 9%.
What is the Gross Profit forecast for Abbott Laboratories?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next 7 years is 9%.
What is the Operating Income forecast for Abbott Laboratories?
Projected CAGR
14%
Over the last 13 years, the compound annual growth rate for Operating Income has been 15%. The projected CAGR for the next 7 years is 14%.
What is the Pre-Tax Income forecast for Abbott Laboratories?
Projected CAGR
18%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 18%.
What is the Net Income forecast for Abbott Laboratories?
Projected CAGR
15%
Over the last 13 years, the compound annual growth rate for Net Income has been 1%. The projected CAGR for the next 7 years is 15%.
